Log In
Print
BCIQ
Print
Print this Print this
 

Inovelon, rufinamide (Banzel) (SYN-111)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionTriazole derivative
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today